In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...
An ENT trainee shared her experience of juggling a medical career with motherhood, exposing the systemic biases faced by ...
Public health initiatives and physical education policies could incorporate ways to support movement among gender-diverse ...
Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...
Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being ...
New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...
Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive ...
Ampatzis’s team mapped the exact composition, organization, and function of neurons in the IcNS using zebrafish as an animal ...
Both radiotherapy and endocrine therapy are good single-modality options for women 70 years or older with early, favorable ...
Patients with low-risk DCIS were randomized to receive either guideline-concordant care or active monitoring and surveyed ...
Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.
Key predictors of prediabetes and diabetes after an episode of acute pancreatitis included baseline severity, elevated ...